• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Cartela AB

edit

Cartela AB is a company principally engaged in research and development within the field of integrin research. Our main focus is centred on two collagen-binding integrins, alpha 10 and alpha 11, present on the cell surface of connective tissue cells.

Recent Milestones

edit

• 
  Cartela AB was acquired by Hansa Medical for $616k. (1/15/08)
  Posted 9/21/09 at 5:43pm
• 
  Cartela AB received $2.67M in Venture Round funding. (4/26/06)
  Posted 4/28/10 at 7:22pm

Videos

Screenshots

edit

Sources

1. Cap Funding Report [edit]
2. Cap Funding Report [edit]